Skip to main content

and
  1. Article

    Open Access

    Mechanism for exercise-mediated prevention against muscle wasting on extensor digitorum longus muscle in Spontaneously Diabetic Torii fatty rats

    We previously reported the significant increase in limb muscle strength and cross-sectional area of the type IIb muscle fibers in the extensor digitorum longus (EDL) muscle in a type 2 diabetic animal model, w...

    Hitoshi Kotake, Yuji Ogura, Shohei Yamada in The Journal of Physiological Sciences (2023)

  2. Article

    Open Access

    Angiotensin II type 1a receptor deficiency alleviates muscle atrophy after denervation

    The study aim was to determine if suppressed activation of angiotensin II type 1 receptor (AT1) prevents severe muscle atrophy after denervation. The sciatic nerves in right and left inferior limbs were cut in...

    Suguru Takayama, Kazuho Inoue, Yuji Ogura, Seiko Hoshino in Scientific Reports (2023)

  3. Article

    Open Access

    Glucagon-like peptide-1 receptor agonist, liraglutide, attenuated retinal thickening in spontaneously diabetic Torii fatty rats

    This study aims to investigate the effect of the glucagon-like peptide-1 (GLP-1) receptor agonist (GLP-1RA) liraglutide on retinal pathological findings as compared with insulin and hydralazine using an animal...

    Kazuho Inoue, Shohei Yamada, Seiko Hoshino, Minoru Watanabe in BMC Ophthalmology (2022)

  4. No Access

    Article

    Renoprotective effect of GLP-1 receptor agonist, liraglutide, in early-phase diabetic kidney disease in spontaneously diabetic Torii fatty rats

    The aim of this study is to investigate the renoprotective effect of the GLP-1 receptor agonist, liraglutide, in early-phase diabetic kidney disease (DKD) using an animal model of type 2 diabetes with several ...

    Shohei Yamada, Jun Tanabe, Yuji Ogura, Yoshio Nagai in Clinical and Experimental Nephrology (2021)

  5. Article

    Open Access

    Angiotensin II type 1a receptor loss ameliorates chronic tubulointerstitial damage after renal ischemia reperfusion

    We investigate whether suppressing the activation of the angiotensin II type 1a receptor (AT1a) can ameliorate severe chronic tubulointerstitial damage (TID) after renal ischemia reperfusion (IR) using AT1a kn...

    Yoko Fujita, Daisuke Ichikawa, Takeshi Sugaya, Keiichi Ohata in Scientific Reports (2021)

  6. No Access

    Article

    Renoprotective effects of voluntary running exercise training on aldosterone-induced renal injury in human L-FABP chromosomal transgenic mice

    Tubulointerstitial damage is a crucial therapeutic target in preventing chronic kidney disease (CKD) progression. Inappropriately activated renin–angiotensin–aldosterone system (RAAS) in the tubulointerstitial...

    Keisei Kosaki Ph.D., Takeshi Sugaya Ph.D., Keiichi Ohata in Hypertension Research (2019)

  7. Article

    Open Access

    Role of bardoxolone methyl, a nuclear factor erythroid 2-related factor 2 activator, in aldosterone- and salt-induced renal injury

    The aim of this study was to investigate the renoprotective effect of bardoxolone methyl (BM), a nuclear factor erythroid 2-related factor 2 (Nrf2) activator with an antioxidant effect, in a salt-sensitive hyp...

    Mikako Hisamichi, Atsuko Kamijo-Ikemori, Takeshi Sugaya in Hypertension Research (2018)